---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-013406"
form_type: "8-K"
ticker: "IKT"
cik: "0001750149"
company_name: "Inhibikase Therapeutics, Inc."
filed_at: "2022-07-29T23:59:59+00:00"
generated_at: "2026-06-24T07:01:19.212694+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Inhibikase receives Nasdaq notice for non-compliance with $1.00 minimum bid price rule

## Summary
- Nasdaq notice dated July 25, 2022; stock bid price below $1.00 for 30 consecutive business days.
- Company has 180 calendar days, until January 23, 2023, to regain compliance.
- To cure, closing bid price must be at least $1.00 for 10 consecutive business days.
- Failure may lead to a second 180-day cure period or delisting, subject to appeal.

## SEC filing metadata
- accession: 0000950170-22-013406
- form_type: 8-K
- ticker: IKT
- cik: 0001750149
- company_name: Inhibikase Therapeutics, Inc.
- filed_at: 2022-07-29T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1750149/000095017022013406/0000950170-22-013406-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1750149/000095017022013406/ikt-20220725.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-013406
- JSON: https://secwatch.observer/filing/0000950170-22-013406.json
- Plain text: https://secwatch.observer/filing/0000950170-22-013406.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.